Journalists are invited to attend the 20th EORTCNCIAACR Symposium on "Molecular Targets and Cancer Therapeutics" in Geneva, Switzerland [Geneva Palexpo, Geneva] from Tuesday 21 October-Friday 24 October.
Today (Monday 15 September) is the deadline for booking accommodation via the official local agent if you wish to attend this symposium, organised jointly by the European Organisation for the Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research.
The symposium offers:
Topics at the news briefings or to be press released include:
Please note: the details contained in this media alert are for information only and are embargoed until the time of the news briefings or press releases.
The symposium is an opportunity for journalists to listen and talk to some of the 2,200 European, American and other international experts in oncology gathered in Geneva to share findings on the latest research on new molecular targets, designer diagnostics and prognostics, smart drugs and other novel approaches to cancer treatment.
NB: the official language of the symposium is English and all press materials will be in English.
Journalists should register to attend the symposium by downloading a registration form at: http://www.ecco-org.eu/ or by contacting Riitta Kettunen:
Tel: +32 2 775 02 05
Fax: +32 2 775 02 00
More information on the programme and hotel accommodation is available on the EORTC-NCI-AACR symposium website at: http://www.ecco-org.eu/
This should be booked through Symporg SA, the official local agent for the symposium, via the symposium website.
Tel: +41-22 839 84 84
Fax: +41-22 839 84 85
NB: the deadline for hotel reservations is September 15. Reservations are made on a first-come, first served basis and you are advised to book early.
|Contact: Emma Mason|
ECCO-the European CanCer Organisation